Get started
Author

Lorenzo Lindo

ORCID: 0000-0001-6731-2752
Observed ORCID: 0000-0001-6731-2752
OpenAlex ID: A5083389009
Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
2021 · Lorenzo Lindo, Lauren Hanna Wilkinson, et al. · Frontiers in Immunology · 85
PDF
Adipose depot-specific upregulation of Ucp1 or mitochondrial oxidative complex proteins are early consequences of genetic insulin reduction in mice
2020 · Jose Diego Botezelli, Peter Overby, et al. · American Journal of Physiology-Endocrinology and Metabolism · 13
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products
2024 · Bo (Angela) Wan, Lorenzo Lindo, et al. · Cytotherapy · 6
Pomalidomide promotes activation induced cell death of pre-activated, memory BCMA CAR-T cells in a model of high, but not low, tumor burden multiple myeloma
2025 · Kirsten Pfeffer, Yuan Zhu, et al. · Blood · 1
PDF
Lymphodepletion Enables Successful BCMA CAR-T Cell Engraftment and Tumour Control in the Syngeneic Vk*MYC Model of Aggressive Myeloma
2023 · Lorenzo Lindo, Erin Meermeier, et al. · Blood · 1
PDF
Clinical Outcomes in Fresh Versus Cryopreserved Hematopoietic Stem Cell Products in British Columbia: A Retrospective Study
2022 · Bo Wan, Lorenzo Lindo, et al. · Blood · 1
BCMA CAR-T Cells Capable of IL-6-Neutralization Bifunctionally Reduce Cytokine Release Syndrome and IL-6-driven Myeloma Growth in Preclinical Models
2025 · Daniel Waller, Lorenzo Lindo, et al. · Clinical Lymphoma Myeloma & Leukemia
A Syngeneic Mouse Model of CAR-T Cell Therapy Containing a Translatable Dual Human/Mouse Reactive sdAb Binder in Vk*MYC Mice Reveals Clinically-Relevant Microenvironment Changes
2025 · Lorenzo Lindo, Daniel Waller, et al. · Clinical Lymphoma Myeloma & Leukemia
BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings
2023 · Stacey N. Lee, Victoria Hoskin, et al. · Biochemistry and Cell Biology
PDF
P-028 Canadian-made single domain antibody (sdAb) BCMA CAR-T cells for multiple myeloma
2023 · Lorenzo Lindo, Daniel Waller, et al. · Clinical Lymphoma Myeloma & Leukemia
Prolonged Maintenance of Ex Vivo Functional Vk*MYC Multiple Myeloma Cells Allows for in Vitro Manipulation and Subsequent In Vivo Analysis
2022 · Frances E Lock, Afsaneh Panahi, et al. · Blood
OAB-006: BCMA CAR T-cells secreting IL-12 to alter the tumour microenvironment in multiple myeloma
2022 · Lorenzo Lindo, Daniel Waller, et al. · Clinical Lymphoma Myeloma & Leukemia
Faculty Opinions recommendation of THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.
2020 · Wilfred Jefferies, Lorenzo Lindo · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Works count: 13
Citation count: 107
H-index: 3
I10-index: 2
Year
Topic
Type